🇺🇸 FDA

Intelligence · Clinical Pipeline

Phase III Pipeline Programs

Late-stage pivotal and registrational clinical programs nearing regulatory submission.

Programs
5,427

Quick answer

NovaPharmaNews tracks 5,427 phase iii pharmaceutical pipeline programs from ClinicalTrials.gov. Late-stage pivotal and registrational clinical programs nearing regulatory submission.

Top sponsors

Page 99 of 114

  1. Vatiquinone

    PTC THERAPEUTICS, INC.

    Friedreich Ataxia

    phase 3 small molecule active

    3 trials

  2. Vatiquinone

    PTC THERAPEUTICS, INC.

    Friedreich ataxia

    phase 3 small molecule active

    1 trial

  3. Vaxneuvance suspension for injection in pre-filled syringe Pneumococcal polysaccharide conjugate vaccine (15-valent, adsorbed), Pneumococcal Conjugate Vaccine (PCV)

    Sanofi-aventis Healthcare Pty Ltd

    Pneumococcal Immunization

    phase 3 small molecule active

    1 trial

  4. Vectibix 20 mg/ml concentrate for solution for infusion

    Fondazione Telethon ETS

    Unresectable left sided RAS/B-RAF wild-type metastatic colorectal cancer

    phase 3 small molecule active

    1 trial

  5. Vedolizumab

    Takeda

    Pouchitis

    phase 3 small molecule active

    1 trial

  6. Vedolizumab

    Takeda

    Ulcerative Colitis

    phase 3 small molecule completed

    9 trials

  7. Vedolizumab

    Takeda

    Colitis, Ulcerative

    phase 3 small molecule completed

    5 trials

  8. Vedolizumab

    Takeda

    Primary Sclerosing Cholangitis

    phase 3 small molecule terminated

    1 trial

  9. Vedolizumab 300 mg IV

    Takeda

    Colitis, Ulcerative

    phase 3 small molecule completed

    1 trial

  10. Vedolizumab IV

    Takeda

    Moderately to Severely Active Ulcerative Colitis

    phase 3 small molecule active

    1 trial

  11. Vedolizumab IV

    Takeda

    Crohn's Disease (CD)

    phase 3 small molecule active

    1 trial

  12. Vedolizumab IV

    Takeda

    Crohn's Disease

    phase 3 small molecule active

    2 trials

  13. Vedolizumab IV

    Takeda

    Ulcerative Colitis

    phase 3 small molecule active

    4 trials

  14. Vedolizumab Placebo

    Takeda

    Hematopoietic Stem Cells

    phase 3 small molecule completed

    1 trial

  15. Vedolizumab SC

    Takeda

    Colitis, Ulcerative

    phase 3 small molecule completed

    1 trial

  16. Vedolizumab SC

    Takeda

    Ulcerative Colitis

    phase 3 small molecule active

    1 trial

  17. Vedolizumab SC 108 mg

    Takeda

    Crohn's Disease

    phase 3 small molecule completed

    1 trial

  18. Vehicle cream (same formulation of cream as the test product but without active substance and the phosphoric acid), Ruxolitinib (INCB018424) cream

    Incyte

    Hidradenitis Suppurativa

    phase 3 small molecule active

    1 trial

  19. Vehicle cream (same formulation of cream as the test product but without active substance), Ruxolitinib (INCB018424) cream

    Incyte

    Prurigo Nodularis

    phase 3 small molecule active

    1 trial

  20. Vehicle cream: same formulation of cream as the test product but without active substance and phosphoric acid, Ruxolitinib (INCB018424) cream

    Incyte

    Atopic Dermatitis

    phase 3 small molecule active

    1 trial

  21. Vehicle cream: same formulation of cream as the test product but without active substance., Ruxolitinib (INCB018424) cream

    Incyte

    Atopic Dermatitis

    phase 3 small molecule active

    1 trial

  22. Vehicle to Mecloderm Ointment, LOTRICOMB® Salbe, 0,64 mg/g + 10 mg/g, Salbe, Mecloderm Ointment

    Alphapharm Pty Ltd

    moderate to severely inflamed candidiasis of the skin

    phase 3 small molecule active

    1 trial

  23. Vehicle to Test Product, Ivermectin Cream, Soolantra 10 mg/g Creme

    Alphapharm Pty Ltd

    Papulopustular Rosacea

    phase 3 small molecule active

    1 trial

  24. Veligrotug

    Viridian Pharma Ltd

    Thyroid Eye Disease

    phase 3 small molecule completed

    1 trial

  25. Veligrotug (VRDN-001)

    Viridian Pharma Ltd

    Thyroid Eye Disease

    phase 3 small molecule completed

    1 trial

  26. Veltassa 8.4 g powder for oral suspension, Placebo

    Istituto Gentili S.r.l.

    End Stage Kidney Disease on chronic dialysis therapy

    phase 3 small molecule active

    1 trial

  27. Vemurafenib

    Hoffmann-La Roche

    Malignant Melanoma

    phase 3 small molecule completed

    2 trials

  28. Venclexta, Venclyxto, Levact 2,5 mg/ml Pulver für ein Konzentrat zur Herstellung einer Infusionslösung, Venclexta, Venclyxto, Fludarabinphosphat "Ebewe", koncentrat til injektions-/infusionsvæske, opløsning, Venclexta, Venclyxto, Fludarabin Ebewe 25 mg/ml injektio-/infuusiokonsentraatti, liuosta varten, Fludarabin Sandoz 25 mg/ml injekčný alebo infúzny koncentrát, MabThera 500 mg concentrate for solution for infusion, Levact 2,5 mg/ml poudre pour solution à diluer pour perfusion, Bendamustin cell pharm® 2,5

    Hoffmann-La Roche

    Chronic Lymphocytic Leukemia (CLL)

    phase 3 small molecule active

    1 trial

  29. Venclyxto 10 mg film-coated tablets, Venclyxto 100 mg film-coated tablets, BGB-11417, MabThera 100 mg concentrate for solution for infusion, BGB-11417, BGB-11417, Gazyvaro 1,000 mg concentrate for solution for infusion., BGB-11417, MabThera 500 mg concentrate for solution for infusion, Venclyxto 50 mg film-coated tablets

    BEONE MEDICINES AUS PTY LTD

    Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

    phase 3 small molecule active

    1 trial

  30. Venclyxto 100 mg film-coated tablets, Levact 2,5 mg/ml poudre pour solution à diluer pour perfusion, BGB-16673, BGB-16673, Venclyxto 10 mg film-coated tablets, Venclyxto 50 mg film-coated tablets, MabThera 500 mg concentrate for solution for infusion, MabThera 100 mg concentrate for solution for infusion, Zydelig 150 mg film-coated tablets, Zydelig 100 mg film-coated tablets

    BEONE MEDICINES AUS PTY LTD

    Chronic lymphotic leukemia and Small Lymphocytic lymphoma

    phase 3 small molecule active

    1 trial

  31. Venclyxto 100 mg film-coated tablets, MabThera 500 mg concentrate for solution for infusion, Zanubrutinib, Venclyxto 50 mg film-coated tablets

    BEONE MEDICINES AUS PTY LTD

    Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

    phase 3 small molecule active

    1 trial

  32. Venetoclax

    The First People's Hospital of Lianyungang

    Acute Myeloid Leukemia

    phase 3 small molecule active

    1 trial

  33. Venetoclax

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Acute Lymphoblastic Leukemia

    phase 3 small molecule active

    1 trial

  34. Venetoclax

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    AML

    phase 3 small molecule active

    2 trials

  35. Venetoclax

    AbbVie

    Chronic Lymphocytic Leukemia

    phase 3 small molecule active

    1 trial

  36. Venetoclax 400

    United Therapeutics Europe Ltd

    Acute Myeloid Leukemia

    phase 3 small molecule active

    1 trial

  37. Venetoclax in combination with fludarabine and melphalan

    The First People's Hospital of Lianyungang

    Venentoclax

    phase 3 small molecule active

    1 trial

  38. Venetoclax, AZACITIDINE, Venetoclax, azacitidine, Venetoclax, azacitidine

    AbbVie Deutschland GmbH & Co. KG

    Acute Myeloid Leukemia in First Remission

    phase 3 small molecule active

    1 trial

  39. Venetoclax, Venetoclax, Cytarabine 100 mg/ml Solution for Injection or Infusion, Matching Placebo for Venetoclax, Venetoclax

    AbbVie Deutschland GmbH & Co. KG

    Acute Myeloid Leukemia

    phase 3 small molecule active

    1 trial

  40. Venetoclax, Venetoclax, Gazyvaro 1,000 mg concentrate for solution for infusion., Calquence 100 mg film-coated tablets, Venetoclax

    AbbVie Deutschland GmbH & Co. KG

    Chronic Lymphocytic Leukemia

    phase 3 small molecule active

    1 trial

  41. Venetoclax, Venetoclax, Matching Placebo for Venetoclax, Venetoclax, AZACITIDINE

    AbbVie Deutschland GmbH & Co. KG

    Acute Myeloid Leukemia

    phase 3 small molecule active

    1 trial

  42. Venetoclax, Venetoclax, Venetoclax, Vidaza 25 mg/ml powder for suspension for injection, Placebo Venetoclax/ABT-199/Film-coated tablet Oral Use

    AbbVie Deutschland GmbH & Co. KG

    Higher-Risk Myelodysplastic Syndrome

    phase 3 small molecule active

    1 trial

  43. Venglustat GZ402671

    Sanofi Pasteur

    Congenital Cystic Kidney Disease

    phase 3 small molecule terminated

    1 trial

  44. Venofer 20 mg iron / ml, solution for injection or concentrate for solution for infusion., Ferumoxytol

    Lacuna Pharma Pty Ltd

    Iron Deficiency Anemia (IDA) in Pediatric Subjects with Chronic Kidney Disease (CKD)

    phase 3 small molecule active

    1 trial

  45. Venofer 20 mg iron / ml, solution for injection or concentrate for solution for infusion., Ferumoxytol

    Lacuna Pharma Pty Ltd

    Iron Deficiency Anemia (IDA)

    phase 3 small molecule active

    1 trial

  46. Venofer 200 MG Per 10 ML Injection

    Arrowhead Pharmaceuticals Ireland Limited

    Iron Deficiency Anemia of Pregnancy

    phase 3 small molecule active

    1 trial

  47. Venticute

    Takeda

    Pneumonia

    phase 3 small molecule completed

    1 trial

  48. Ventoclax

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    AML (Acute Myelogenous Leukemia)

    phase 3 small molecule active

    1 trial

Frequently asked questions

How many Phase III pipeline programs are in the directory?

5,427 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.